177Lu-Vipivotide Tetraxetan (177Lu-PSMA-617, Pluvicto) Therapy

被引：1
|
作者：
Clements, Sarah
Tempesta, Daniel
Jacene, Heather
机构：
来源：
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | 2022年 / 50卷 / 03期
关键词：
D O I：
10.2967/jnmt.122.264731
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：213 / 214
页数：2
相关论文
共 50 条
  • [1] The 177Lu-PSMA-617 (Pluvicto) Supply Problem Will Be Solved by Competition
    Czernin, Johannes
    Calais, Jeremie
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (03) : 343 - 343
  • [2] Patient characteristics, treatment patterns and early trends of lutetium Lu 177 vipivotide tetraxetan (177Lu-PSMA-617) use by US urologists and oncologists
    Nguyen, Jennifer
    Patel, Jeetvan
    Kang, Barinder
    Yu, Channing
    Sawhney, Amrita
    Fallick, Mark
    Gorritz, Magdaliz
    Chen, Chi-Chang
    Paltanwale, Queenie
    Sun, Kainan
    Shore, Neal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Radiation Dosimetry in 177Lu-PSMA-617 Therapy
    Jackson, Price
    Hofman, Michael
    McIntosh, Lachlan
    Buteau, James Patrick
    Kumar, Aravind Ravi
    SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (02) : 243 - 254
  • [4] A Hangover Under 177Lu-PSMA-617 Therapy
    Poterszman, Nathan
    Somme, Laura
    Bund, Caroline
    Hutt, Emilie
    Somme, Francois
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : 582 - 583
  • [5] Patient characteristics and overall survival with lutetium (Lu177) vipivotide tetraxetan (177Lu-PSMA-617): A real-world analysis of early adopters.
    George, Daniel J.
    Shore, Neal D.
    Nguyen, Jennifer
    Patel, Jeetvan
    Sawhney, Amrita
    Kang, Barinder
    Chen, Chi-Chang
    Gorritz, Magdaliz
    Wei, Xiao X.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [6] Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy
    Mair, Christian
    Warwitz, Boris
    Fink, Katharina
    Scarpa, Lorenza
    Nilica, Bernhard
    Maffey-Steffan, Johanna
    Buxbaum, Sabine
    Virgolini, Irene J.
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (07) : 499 - 502
  • [7] Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy
    Christian Mair
    Boris Warwitz
    Katharina Fink
    Lorenza Scarpa
    Bernhard Nilica
    Johanna Maffey-Steffan
    Sabine Buxbaum
    Irene J. Virgolini
    Annals of Nuclear Medicine, 2018, 32 : 499 - 502
  • [8] Administration of 177Lu-PSMA-617 as Compared to 177Lu-Dotatate
    Patel, P.
    McCall, K.
    MEDICAL PHYSICS, 2022, 49 (06) : E811 - E812
  • [9] 177Lu-PSMA-617: Brazilian Experience
    Villas Boas, Cristian Wieczorek
    Silva, Jefferson de Jesus
    Benedetto, Raquel
    Mengatti, Jair
    De Araujo, Elaine Bortoleti
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [10] Logistics of Adopting 177Lu-Vipivotide Tetraxetan Therapy in a Community-Based Hospital Setting
    Marsh, Kathleen
    Allickson, Kayla
    Jesz, Amanda
    Hanson, Cheryl
    Newman, Donna
    Martin-Macintosh, Erica
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2025, 53 (01) : 68 - 71
12345